Auspex Pharmaceuticals Inc (ASPX)

100.96
0.01 0.01
Prev Close 100.95
Open 100.96
Day Low/High 100.94 / 101.00
52 Wk Low/High 14.75 / 101.00
Volume 687.72K
Avg Volume 619.80K
Exchange
Shares Outstanding 31.83M
Market Cap 3.21B
EPS -2.68
Div & Yield N.A. (N.A)

Latest News

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Mylan's deal to buy Perrigo is taking another potential target off the block.

ASPX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Auspex Pharmaceuticals Inc. Concerning The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

ASPX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Auspex Pharmaceuticals Inc. Concerning The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Auspex Pharmaceuticals Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Auspex Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Auspex Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auspex Pharmaceuticals, Inc.

ASPX INVESTOR ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Auspex Pharmaceuticals Inc. In Connection With The Sale Of The Company To Teva Pharmaceutical Industries Ltd. - ASPX

ASPX INVESTOR ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Auspex Pharmaceuticals Inc. In Connection With The Sale Of The Company To Teva Pharmaceutical Industries Ltd. - ASPX

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Auspex Pharmaceuticals Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Auspex Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Auspex Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Auspex...

Biotech Stocks? Proceed With Caution

Biotech Stocks? Proceed With Caution

Mergers are driving up biotech stocks, but beware of short traders.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Auspex Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Auspex Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auspex Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Auspex Pharmaceuticals Inc. Of Commencement Of An Investigation In Connection With The Fairness Of The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Auspex Pharmaceuticals Inc. Of Commencement Of An Investigation In Connection With The Fairness Of The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

The following statement is being issued by Levi & Korsinsky, LLP: TO: ALL PERSONS OR ENTITIES WHO PURCHASED AUSPEX PHARMACEUTICALS INC.

George Soros Might Invest $1 Billion in Ukraine -- Here's Where Else He's Investing

George Soros Might Invest $1 Billion in Ukraine -- Here's Where Else He's Investing

George Soros said this week that he is ready to pour $1 billion in Ukraine. With a $24 billion personal fortune, he can certainly afford it.

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Large pharmas continued the shopping spree, paying no attention to whispers of a biotech bubble.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Auspex Pharmaceuticals, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Auspex Pharmaceuticals, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Auspex Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Auspex Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Auspex Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Auspex...

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

The stock markets in the United States rallied today driven by optimism among investors that central banks will support the global economic growth. The markets also benefitted from reports on corporat...

AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Teva Pharmaceutical Industries Ltd. May Be Unfair To Shareholders

AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Teva Pharmaceutical Industries Ltd. May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Auspex...

Stock Markets Soar on Trifecta of Good News

Stock Markets Soar on Trifecta of Good News

Stocks recapture positive territory for the year on a spate of pharma deals, as well as positive news from the Fed and China.

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Stocks recapture positive territory for the year.

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion

The Israeli drug company thinks the biopharmaceutical drug developer will strengthen its position in its core central nervous system segment.

Teva Pharmaceutical Swallows Auspex to Strengthen Its Drug Pipeline

Teva Pharmaceutical Swallows Auspex to Strengthen Its Drug Pipeline

Israeli drug company Teva Pharmaceutical Industries is buying Auspex Pharmaceuticals, with its portfolio of drugs to treat Tourette Syndrome, Huntington's chorea and a variety of other maladies.

Stocks Reclaim Year-to-Date Gains as China Talks Monetary Easing

Stocks Reclaim Year-to-Date Gains as China Talks Monetary Easing

Stocks begin the holiday-shortened week with a bounce following a deluge of big pharma M&A deals on Monday morning.

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

Neither of the deals announced Monday are blockbusters or particularly transformative. Both buyers have specific needs and went after small targets for large prices.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Auspex Pharmaceuticals Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Auspex Pharmaceuticals Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Teva Pharmaceutical Industries Ltd.

The following statement is being issued by Levi & Korsinsky, LLP: TO: ALL PERSONS OR ENTITIES WHO PURCHASED AUSPEX PHARMACEUTICALS INC.

Stock Futures Are Driving Higher Amid Big Pharma Mergers

Stock Futures Are Driving Higher Amid Big Pharma Mergers

Stock futures set up for a nice bounce to begin the week following a deluge of big pharma deals on Monday morning.

Teva Buying Auspex Pharma for $3.5 Billion in Bid to Restart Growth

Teva Buying Auspex Pharma for $3.5 Billion in Bid to Restart Growth

Teva said it would acquire smaller companies as a way to offset the expected revenue hit coming when its multiple sclerosis drug Copaxone faces generic competition in September.

Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results And Business Highlights

Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results And Business Highlights

On Track to Submit Austedo(TM) NDA for Chorea Associated With Huntington's Disease in Mid-2015